• Home
  • News
    • Saturday, Dec. 9
    • Friday, Dec. 8
    • Thursday, Dec. 7
    • Wednesday, Dec. 6
    • Tuesday, Dec. 5
    • Monday, Dec. 4
    • 2023 Pre-Meeting
      • Nov. 20
      • Nov. 7
      • Oct. 17
      • Oct. 3
      • Sept. 19
      • Sept. 7
    • Archive
      • 2023
      • 2022
      • 2021
      • 2020
  • Attendee Map & Photos
  • Special Editions
  • Industry Events
    • Product Theaters
    • Satellite Educational Symposia
  • Featured Exhibitors
Meeting Home
Get News Updates
  • Home
  • News
    • Saturday, Dec. 9
    • Friday, Dec. 8
    • Thursday, Dec. 7
    • Wednesday, Dec. 6
    • Tuesday, Dec. 5
    • Monday, Dec. 4
    • 2023 Pre-Meeting
      • Nov. 20
      • Nov. 7
      • Oct. 17
      • Oct. 3
      • Sept. 19
      • Sept. 7
    • Archive
      • 2022
      • 2021
      • 2020
      • 2023
  • Attendee Map & Photos
  • Special Editions
  • Industry Events
    • Product Theaters
    • Satellite Educational Symposia
  • Featured Exhibitors
  • Get News Updates

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer

November 1, 2023

//

Estimated Read Time:

1 minute

«Previous: A Practical “How-To” Guide for Selection, Sequencing, and Optimal Use of HER2-Targeted Therapies in HER2-Positive Breast Cancer
Next: Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs»
  • Twitter
  • Facebook
  • Instagram

© 2023 SABCS. All Rights Reserved. Powered By TriStar Event Media, LLC.

Privacy Policy

Get email updates from SABCSMeetingNews.org

Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.